-
-
-
-
-
-
-
Nkarta (NKTX) Reiterated at Buy by Stifel; Estimates Largely Unchanged
-
-
-
-
-
-
-
William Blair Downgrades Nkarta Inc. (NKTX) to Market Perform
-
-
-
-
-
-
-
Nkarta Inc. (NKTX) PT Lowered to $20 at Mizuho
-
-
-
-
-
-
-
Nkarta (NKTX) Initiates Clinical Trial of NKX019
-
445,823 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

